{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:37:30Z","timestamp":1791275850680,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.soc.2017.11.010","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T00:54:53Z","timestamp":1513299293000},"page":"377-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Surgical Treatment of Metastatic Colorectal Cancer"],"prefix":"10.1016","volume":"27","author":[{"given":"Jeffery","family":"Chakedis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl R.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.soc.2017.11.010_bib1","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy","volume":"27","author":"Kopetz","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2017.11.010_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0029-1242462","article-title":"Surgical management of colorectal liver metastases","volume":"22","author":"Mohammad","year":"2009","journal-title":"Clin Colon Rectal Surg"},{"issue":"16","key":"10.1016\/j.soc.2017.11.010_bib3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2014.59.7633","article-title":"Metastatic colorectal cancer: current state and future directions","volume":"33","author":"Fakih","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/annonc\/mdf034","article-title":"Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients","volume":"13","author":"Kohne","year":"2002","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jamcollsurg.2007.04.039","article-title":"Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases","volume":"205","author":"Miller","year":"2007","journal-title":"J\u00a0Am Coll Surg"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2017.11.010_bib7","series-title":"Blumgart's surgery of the liver, pancreas and biliary tract","article-title":"Metastatic malignant liver tumors: colorectal cancer","author":"Winter","year":"2012"},{"key":"10.1016\/j.soc.2017.11.010_bib8","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1038\/ncomms4530","article-title":"Lymph node-independent liver metastasis in a model of metastatic colorectal cancer","volume":"5","author":"Enquist","year":"2014","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.soc.2017.11.010_bib9","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1200\/JCO.2011.38.2994","article-title":"Comparative genomic analysis of primary versus metastatic colorectal carcinomas","volume":"30","author":"Vakiani","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.soc.2017.11.010_bib10","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1245\/s10434-007-9557-7","article-title":"Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum","volume":"14","author":"Varghese","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.soc.2017.11.010_bib11","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/annonc\/mdu252","article-title":"Clinicopathologic characteristics and gene expression analyses of non-KRAS 12\/13, RAS-mutated metastatic colorectal cancer","volume":"25","author":"Morris","year":"2014","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/annonc\/mdt591","article-title":"Metastatic pattern in colorectal cancer is strongly influenced by histological subtype","volume":"25","author":"Hugen","year":"2014","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.soc.2017.11.010_bib13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/cncr.29196","article-title":"RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer","volume":"121","author":"Yaeger","year":"2015","journal-title":"Cancer"},{"issue":"36","key":"10.1016\/j.soc.2017.11.010_bib14","doi-asserted-by":"crossref","first-page":"38658","DOI":"10.18632\/oncotarget.6130","article-title":"Pattern of distant metastases in colorectal cancer: a SEER based study","volume":"6","author":"Qiu","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib15","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/SLA.0b013e3181fcf3e3","article-title":"Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?","volume":"252","author":"Adam","year":"2010","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1245\/s10434-012-2424-1","article-title":"Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival","volume":"20","author":"Nanji","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"9617","key":"10.1016\/j.soc.2017.11.010_bib17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.soc.2017.11.010_bib18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1470-2045(14)70105-6","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial","volume":"15","author":"Primrose","year":"2014","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.soc.2017.11.010_bib20","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2007.13.7679","article-title":"Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer","volume":"26","author":"Gruenberger","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/SLA.0b013e3182a6183e","article-title":"Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival","volume":"258","author":"Vigano","year":"2013","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.soc.2017.11.010_bib22","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/sj.bjc.6603670","article-title":"Safe liver resection following chemotherapy for colorectal metastases is a matter of timing","volume":"96","author":"Welsh","year":"2007","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.soc.2017.11.010_bib23","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1245\/s10434-010-1166-1","article-title":"Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases","volume":"17","author":"Kishi","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.soc.2017.11.010_bib24","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1245\/s10434-012-2438-8","article-title":"Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis","volume":"19","author":"Robinson","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","article-title":"Epidemiology and management of liver metastases from colorectal cancer","volume":"244","author":"Manfredi","year":"2006","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.soc.2017.11.010_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ctrv.2015.06.006","article-title":"Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus","volume":"41","author":"Adam","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"10.1016\/j.soc.2017.11.010_bib27","article-title":"Colorectal stents for the management of malignant colonic obstructions","author":"Sagar","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jamcollsurg.2012.08.030","article-title":"Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience","volume":"216","author":"Wolf","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"issue":"8","key":"10.1016\/j.soc.2017.11.010_bib29","doi-asserted-by":"crossref","first-page":"e104348","DOI":"10.1371\/journal.pone.0104348","article-title":"Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suitable\u2013a meta-analysis","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jamcollsurg.2009.01.031","article-title":"Simultaneous versus staged resection for synchronous colorectal cancer liver metastases","volume":"208","author":"Martin","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"issue":"8","key":"10.1016\/j.soc.2017.11.010_bib31","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s00268-015-3034-4","article-title":"Laparoscopic simultaneous resection of colorectal primary tumor and liver metastases: results of a multicenter international study","volume":"39","author":"Ferretti","year":"2015","journal-title":"World J Surg"},{"issue":"20","key":"10.1016\/j.soc.2017.11.010_bib32","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1200\/JCO.2008.20.9817","article-title":"Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment","volume":"27","author":"Poultsides","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2017.11.010_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/SLA.0000000000000860","article-title":"Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity score-adjusted trend analysis","volume":"262","author":"Tarantino","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2017.11.010_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejca.2014.10.023","article-title":"Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials","volume":"51","author":"Faron","year":"2015","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.soc.2017.11.010_bib35","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1245\/s10434-014-3805-4","article-title":"A\u00a0meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival","volume":"21","author":"Clancy","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2017.11.010_bib36","first-page":"e41","article-title":"Surgical resection of primary tumor in asymptomatic or minimally symptomatic patients with stage IV colorectal cancer: a Canadian province experience","volume":"14","author":"Ahmed","year":"2015","journal-title":"Clin Colorectal Cancer"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib37","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1245\/s10434-013-3463-y","article-title":"Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection","volume":"21","author":"Ghiringhelli","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.soc.2017.11.010_bib38","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.critrevonc.2010.08.001","article-title":"Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection","volume":"79","author":"Power","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"36","key":"10.1016\/j.soc.2017.11.010_bib40","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1200\/JCO.2012.45.2854","article-title":"Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases","volume":"30","author":"Shindoh","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"29","key":"10.1016\/j.soc.2017.11.010_bib41","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1200\/JCO.2007.11.0833","article-title":"Actual 10-year survival after resection of colorectal liver metastases defines cure","volume":"25","author":"Tomlinson","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1477-2574.2012.00557.x","article-title":"Selection for hepatic resection of colorectal liver metastases: expert consensus statement","volume":"15","author":"Adams","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"8","key":"10.1016\/j.soc.2017.11.010_bib43","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1245\/s10434-009-0521-6","article-title":"Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center","volume":"16","author":"Carpizo","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SLA.0b013e31815aa2c2","article-title":"Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients","volume":"247","author":"Rees","year":"2008","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.sla.0000160703.75808.7d","article-title":"Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases","volume":"241","author":"Pawlik","year":"2005","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0b013e3181b4539b","article-title":"Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients","volume":"250","author":"de Jong","year":"2009","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib47","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jamcollsurg.2009.12.040","article-title":"Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution","volume":"210","author":"House","year":"2010","journal-title":"J\u00a0Am Coll Surg"},{"issue":"9","key":"10.1016\/j.soc.2017.11.010_bib48","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.hpb.2016.06.004","article-title":"Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis","volume":"18","author":"Memeo","year":"2016","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/SLA.0000000000001194","article-title":"Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival","volume":"263","author":"Mise","year":"2016","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.soc.2017.11.010_bib50","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1245\/s10434-007-9522-5","article-title":"Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis","volume":"14","author":"Reddy","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"10.1016\/j.soc.2017.11.010_bib51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJMra065156","article-title":"Strategies for safer liver surgery and partial liver transplantation","volume":"356","author":"Clavien","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jamcollsurg.2012.10.018","article-title":"Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant","volume":"216","author":"Shindoh","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib53","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/SLA.0000000000001449","article-title":"Failure to achieve a 2-stage hepatectomy for colorectal liver metastases: how to prevent it?","volume":"262","author":"Imai","year":"2015","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.soc.2017.11.010_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1477-2574.2012.00607.x","article-title":"A\u00a0systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases","volume":"15","author":"Lam","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"8","key":"10.1016\/j.soc.2017.11.010_bib55","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1200\/JCO.2010.32.6132","article-title":"High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome","volume":"29","author":"Brouquet","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/archsurg.2010.248","article-title":"Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal","volume":"146","author":"Nguyen","year":"2011","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib57","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/SLA.0000000000002147","article-title":"Laparoscopic versus open liver resection for colorectal metastases in elderly and octogenarian patients: a multicenter propensity score based analysis of short- and long-term outcomes","volume":"265","author":"Martinez-Cecilia","year":"2017","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib58","first-page":"1146","article-title":"Laparoscopic versus open hepatectomy for elderly patients with liver metastases from colorectal cancer","volume":"21","author":"Zeng","year":"2016","journal-title":"J\u00a0Buon"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib59","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/SLA.0000000000001475","article-title":"Early and long-term oncological outcomes after laparoscopic resection for colorectal liver metastases: a propensity score-based analysis","volume":"262","author":"Allard","year":"2015","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib60","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/SLA.0b013e3181bd93b2","article-title":"The learning curve in laparoscopic liver resection: improved feasibility and reproducibility","volume":"250","author":"Vigano","year":"2009","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.soc.2017.11.010_bib61","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/bjs.9213","article-title":"Surgical management of disappearing colorectal liver metastases","volume":"100","author":"Bischof","year":"2013","journal-title":"Br J Surg"},{"issue":"24","key":"10.1016\/j.soc.2017.11.010_bib62","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2006.05.8727","article-title":"Complete response of colorectal liver metastases after chemotherapy: does it mean cure?","volume":"24","author":"Benoist","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"33","key":"10.1016\/j.soc.2017.11.010_bib63","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/hpb.12159","article-title":"Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases","volume":"16","author":"Devaud","year":"2014","journal-title":"HPB (Oxford)"},{"issue":"8","key":"10.1016\/j.soc.2017.11.010_bib65","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1245\/s10434-015-4370-1","article-title":"Recurrence after partial hepatectomy for metastatic colorectal cancer: potentially curative role of salvage repeat resection","volume":"22","author":"Butte","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.soc.2017.11.010_bib66","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s11605-013-2186-5","article-title":"A\u00a0systematic review of repeat hepatectomy for recurrent colorectal liver metastases","volume":"17","author":"Lam","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib67","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/bjs.9088","article-title":"Repeat hepatectomy for recurrent colorectal metastases","volume":"100","author":"Wicherts","year":"2013","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/hpb.12096","article-title":"Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience","volume":"16","author":"Battula","year":"2014","journal-title":"HPB (Oxford)"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib69","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib70","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/jso.23689","article-title":"Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases","volume":"110","author":"Eltawil","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"10","key":"10.1016\/j.soc.2017.11.010_bib71","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/annonc\/mds053","article-title":"Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)","volume":"23","author":"Ruers","year":"2012","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.soc.2017.11.010_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx015","article-title":"Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial","volume":"109","author":"Ruers","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib73","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ejca.2013.12.008","article-title":"Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983","volume":"50","author":"Tanis","year":"2014","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib74","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1245\/s10434-011-2048-x","article-title":"Patterns of recurrence after ablation of colorectal cancer liver metastases","volume":"19","author":"Kingham","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib75","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/SLA.0000000000000976","article-title":"Two-stage hepatectomy versus 1-stage resection combined with radiofrequency for bilobar colorectal metastases: a case-matched analysis of surgical and oncological outcomes","volume":"260","author":"Faitot","year":"2014","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.soc.2017.11.010_bib76","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1245\/ASO.2003.03.026","article-title":"Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients","volume":"10","author":"Pawlik","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib77","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.suc.2015.11.002","article-title":"Hepatic artery infusional chemotherapy","volume":"96","author":"Lewis","year":"2016","journal-title":"Surg Clin North Am"},{"issue":"27","key":"10.1016\/j.soc.2017.11.010_bib78","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","article-title":"Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer","volume":"341","author":"Kemeny","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2017.11.010_bib79","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM200502173520723","article-title":"Hepatic arterial infusion after liver resection","volume":"352","author":"Kemeny","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib80","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/SLA.0b013e31822f4f88","article-title":"Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer","volume":"254","author":"House","year":"2011","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2005.03.019","article-title":"Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases","volume":"201","author":"Allen","year":"2005","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib82","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1245\/s10434-013-3275-0","article-title":"Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab","volume":"21","author":"Cercek","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib83","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","article-title":"Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial","volume":"11","author":"Folprecht","year":"2010","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.soc.2017.11.010_bib84","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1093\/annonc\/mdq714","article-title":"A\u00a0multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection","volume":"22","author":"Wong","year":"2011","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib85","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00432-014-1833-x","article-title":"Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib86","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1245\/s10434-008-0179-5","article-title":"A\u00a0phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer","volume":"16","author":"Zeh","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2017.11.010_bib87","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib88","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/SLA.0000000000000614","article-title":"Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes","volume":"261","author":"D'Angelica","year":"2015","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib89","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1055-3207(03)00044-9","article-title":"Natural history of peritoneal carcinomatosis from nongynecologic malignancies","volume":"12","author":"Glehen","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"issue":"7","key":"10.1016\/j.soc.2017.11.010_bib90","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bjc.2013.82","article-title":"Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades","volume":"108","author":"Kerscher","year":"2013","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.soc.2017.11.010_bib91","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.soc.2017.11.010_bib92","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib93","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2017.11.010_bib94","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","article-title":"Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy","volume":"38","author":"Klaver","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib95","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","author":"Spratt","year":"1980","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib97","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1055-3207(03)00037-1","article-title":"Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma","volume":"12","author":"Glehen","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib98","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1245\/s10434-013-3061-z","article-title":"Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States","volume":"21","author":"Turaga","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib99","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"da Silva","year":"2006","journal-title":"J\u00a0Am Coll Surg"},{"issue":"13","key":"10.1016\/j.soc.2017.11.010_bib100","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1245\/s10434-014-3798-z","article-title":"The American Society of Peritoneal Surface Malignancies (ASPSM) multiinstitution evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis","volume":"21","author":"Esquivel","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"10.1016\/j.soc.2017.11.010_bib101","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib102","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2017.11.010_bib103","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","article-title":"Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients","volume":"218","author":"Levine","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib104","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","article-title":"Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American College of Surgeons national surgical quality improvement program","volume":"149","author":"Jafari","year":"2014","journal-title":"JAMA Surg"},{"issue":"16","key":"10.1016\/j.soc.2017.11.010_bib105","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.soc.2017.11.010_bib106","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib107","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.soc.2017.11.010_bib108","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00432-013-1517-y","article-title":"Peritoneal metastases of lower gastrointestinal tract origin: a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy","volume":"139","author":"Ung","year":"2013","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"13","key":"10.1016\/j.soc.2017.11.010_bib109","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","article-title":"Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol","volume":"20","author":"Kuijpers","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib110","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","article-title":"Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?","volume":"257","author":"Goere","year":"2013","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib111","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1245\/s10434-014-3985-y","article-title":"Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"22","author":"Baumgartner","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2017.11.010_bib112","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ejso.2013.10.022","article-title":"Repeat cytoreductive surgery (CRS) for recurrent colorectal peritoneal metastases: yes or no?","volume":"40","author":"Williams","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.soc.2017.11.010_bib113","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/gut.2010.211557","article-title":"Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study","volume":"59","author":"Mitry","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.soc.2017.11.010_bib114","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s11605-008-0757-7","article-title":"How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years","volume":"13","author":"Tan","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.soc.2017.11.010_bib115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1477-7819-12-197","article-title":"Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy","volume":"12","author":"Chiang","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2017.11.010_bib116","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10585-015-9774-6","article-title":"Management of resectable colorectal lung metastases","volume":"33","author":"Moorcraft","year":"2016","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib117","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/bjs.4370","article-title":"Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer","volume":"91","author":"Kanemitsu","year":"2004","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib118","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.athoracsur.2009.03.034","article-title":"Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases","volume":"87","author":"Onaitis","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib119","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00384-010-1075-6","article-title":"Role of surgical resection in colorectal lung metastases: analysis of 137 patients","volume":"26","author":"Borasio","year":"2011","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib120","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.athoracsur.2012.07.014","article-title":"Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer","volume":"94","author":"Blackmon","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.soc.2017.11.010_bib121","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.athoracsur.2014.05.048","article-title":"Lung metastases from colorectal cancer: analysis of prognostic factors in a single institution study","volume":"98","author":"Zampino","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib122","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/annonc\/mdw064","article-title":"Role of major resection in pulmonary metastasectomy for colorectal cancer in the Spanish prospective multicenter study (GECMP-CCR)","volume":"27","author":"Hernandez","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.soc.2017.11.010_bib123","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.athoracsur.2007.02.093","article-title":"Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series","volume":"84","author":"Pfannschmidt","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"10.1016\/j.soc.2017.11.010_bib124","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1634\/theoncologist.2012-0142","article-title":"The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study","volume":"17","author":"Tampellini","year":"2012","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.soc.2017.11.010_bib125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002787","article-title":"Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR)","volume":"3","author":"Embun","year":"2013","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib126","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1245\/s10434-012-2726-3","article-title":"Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis","volume":"20","author":"Gonzalez","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2017.11.010_bib127","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00268-011-1381-3","article-title":"Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases","volume":"36","author":"Gonzalez","year":"2012","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.soc.2017.11.010_bib128","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ejso.2011.05.014","article-title":"Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor","volume":"37","author":"Zabaleta","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2017.11.010_bib129","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/bjs.9783","article-title":"Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases","volume":"102","author":"Andres","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.soc.2017.11.010_bib130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1186\/1471-2407-14-619","article-title":"Stereotactic ablative radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach","volume":"14","author":"Comito","year":"2014","journal-title":"BMC Cancer"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105532071730128X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105532071730128X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:02:25Z","timestamp":1760961745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105532071730128X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":130,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S105532071730128X"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2017.11.010","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Treatment of Metastatic Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2017.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}